Arbeitsgruppe Kopf-Hals-Tumoren - Studien

AIO-assoziierte-Studie
  zur Studie
  AIO-KHT-0121/ass: First-line treatment of locally advanced HNSCC with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+ T cell infiltration (CheckRad-CD8)
  ---Rekrutierung beendet---
operable Kopf-Hals Tumoren

AIO-assoziierte-Studie
www.clinicaltrials.gov zur Studie
  AIO-KHT-0220/ass: Window of opportunity study of preoperative immunotherapy with atezolizumab (Tecentriq®) or FAP-interleukin 2v (IL2v) (RO6874281) in local squamous cell carcinoma of the head and neck – an imCORE Study (PIONEER)
  ---in Rekrutierung---
LETZTE AKTUALISIERUNG DIESER SEITE AM: 05.11.2021